FOGAR, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.880
EU - Europa 1.304
AS - Asia 1.198
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 4
SA - Sud America 3
Totale 12.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.866
CN - Cina 815
FI - Finlandia 343
SE - Svezia 251
DE - Germania 207
SG - Singapore 191
IT - Italia 188
UA - Ucraina 159
VN - Vietnam 109
GB - Regno Unito 73
IN - India 23
KR - Corea 23
EU - Europa 18
IE - Irlanda 16
RU - Federazione Russa 15
FR - Francia 13
NL - Olanda 13
CA - Canada 12
JP - Giappone 9
RO - Romania 7
IR - Iran 6
SI - Slovenia 6
TR - Turchia 5
TW - Taiwan 5
AT - Austria 3
BG - Bulgaria 3
BR - Brasile 3
HK - Hong Kong 3
ID - Indonesia 3
IQ - Iraq 3
AU - Australia 2
BE - Belgio 2
ES - Italia 2
MX - Messico 2
NZ - Nuova Zelanda 2
CZ - Repubblica Ceca 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.407
Salva come PNG Salva come JPEG
Città #
Fairfield 1.086
Chandler 1.084
Woodbridge 1.057
Ann Arbor 957
Houston 792
Jacksonville 763
Ashburn 662
Wilmington 538
Cambridge 433
Seattle 368
Princeton 260
Des Moines 207
Beijing 199
Medford 198
Nanjing 159
Helsinki 126
Singapore 117
Dong Ket 109
Roxbury 106
Boardman 96
San Diego 92
Guangzhou 61
Nanchang 52
Shenyang 45
Hebei 39
Padova 38
New York 34
Tianjin 34
Changsha 30
Jiaxing 30
Jinan 24
Norwalk 24
London 20
Zhengzhou 20
Gangdong-gu 19
Los Angeles 18
Redwood City 16
Shanghai 16
Dublin 15
Detroit 12
Borås 11
Rome 10
Bologna 9
Indiana 9
Kharkiv 9
Pune 9
Taizhou 9
Washington 9
Haikou 8
Lanzhou 8
Ningbo 8
Hangzhou 7
Kunming 7
Milan 7
Ogden 7
Rockville 7
Cagliari 6
Falls Church 6
Hefei 6
Kilburn 6
Turin 6
Lappeenranta 5
Mestre 5
Montreal 5
Munich 5
Nürnberg 5
San Francisco 5
Yellow Springs 5
Amsterdam 4
Fuzhou 4
Tappahannock 4
Yenibosna 4
Augusta 3
Bucharest 3
Chengdu 3
Dearborn 3
Florence 3
Okazaki 3
Phoenix 3
Saint Petersburg 3
Sofia 3
Taiyuan 3
Udine 3
Vicenza 3
Wuhan 3
Atlanta 2
Baotou 2
Bari 2
Brescia 2
Cantù 2
Chicago 2
Fremont 2
Gallio 2
Geislingen an der Steige 2
Genoa 2
Genova 2
Ghent 2
Guadalajara 2
Hamburg 2
Hong Kong 2
Totale 10.240
Salva come PNG Salva come JPEG
Nome #
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 173
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 173
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 154
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 137
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 129
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 126
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 125
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 121
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 116
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 114
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 110
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 109
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 106
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 105
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 102
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 102
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 101
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 99
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 99
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 99
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 98
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 98
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 95
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 94
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 93
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 93
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 92
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 92
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 92
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 91
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 90
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 89
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 88
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 87
Biological variability of lymphocyte subsets of human adults’ blood 85
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 84
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 84
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 83
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 82
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 82
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 81
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 81
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 81
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 80
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 80
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 78
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 78
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 78
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 78
Urinary phospholipase A2 excretion in chronic pancreatic diseases 78
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 77
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 74
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 73
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 73
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 72
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 71
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 71
Urinary kallikrein excretion in chronic pancreatic diseases. 71
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 70
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 70
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 70
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 70
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 69
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 68
NT-S100A8 effects on cell signalling. 67
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 67
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 67
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 66
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 66
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 66
Gastropanel: a useful screening test in paediatric populations 65
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 64
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 64
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 64
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 64
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 64
Carcinogenetic potential of the WSR cagA region. 64
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 63
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 63
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 63
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 62
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 62
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 61
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 61
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 61
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 60
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 59
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 59
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 58
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 58
Engineering diphteria toxin in pancreatic cancer cells: a promising tool for therapy. 57
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 57
Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment? 57
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 57
Beta-cell function in pancreatic adenocarcinoma. 56
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 56
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 56
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 54
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1 54
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 53
Totale 8.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.672
article - articoli 18.983
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019260 0 0 0 0 0 0 0 0 0 0 0 260
2019/20202.266 413 57 54 157 191 160 151 252 210 334 163 124
2020/20211.549 76 142 71 120 85 109 21 151 210 170 197 197
2021/20221.871 27 368 146 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
Totale 12.471